Emerging evidence links hormonal imbalance to metabolic dysfunction, oxidative stress, and elevated cardiovascular risk. Conditions marked by insulin resistance, dyslipidemia, and obesity share disrupted endocrine signaling that accelerates cardiometabolic complications across populations.
Source : https://pubmed.ncbi.nlm.nih.gov/41607827/
Post-transplant obesity arises from a complex interplay of pharmacological, behavioral, and molecular factors. A multidisciplinary approach-incorporating pharmacological modification, nutritional management, physical activity, and molecular-targeted therapies-is essential to mitigate obesity and...
Systematic review identifies pharmacological, behavioral, and molecular drivers of post-transplant obesity, highlighting immunosuppressant effects, lifestyle factors, and adipokine dysregulation, and advocating multidisciplinary strategies to improve long-term transplant outcomes.
Source : https://pubmed.ncbi.nlm.nih.gov/41517662/
Regular follow-up and the frequency of outpatient clinic visits are crucial factors in the management of obesity. This study aimed to assess the impact of the number and frequency of...
Retrospective study shows higher number and frequency of obesity clinic visits significantly improve weight loss outcomes, identifying visit thresholds that predict ≥5% weight loss and support regular follow-up for sustained success.
Source : https://pubmed.ncbi.nlm.nih.gov/41523739/
Group and supervised interventions appear effective in improving exercise adherence among adults with overweight or obesity, but further high-quality studies are needed.
This systematic review found group-based and supervised exercise interventions most effective for improving adherence in adults with overweight or obesity, though evidence quality was limited and further high-quality studies are needed.